Furthermore, findings from Colomba et al. (2019) underscore ALT as a marker of glucose abnormality in males with cystic fibrosis, prompting exploration into the interplay between liver disease phenotype, fibrosis risk, and the development of impaired glucose tolerance [109]. The gene discussed is GPT; the disease is Impaired glucose tolerance.